| Stage | CSCO | % of rev | EXTR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $17.3B | 100.00% | $341M | 100.00% | CSCO ×50.58 |
| Gross profit | $11.1B | 64.13% | $212M | 62.13% | CSCO +2.0pp |
| Operating income | $4.3B | 24.72% | $23M | 6.77% | CSCO +17.9pp |
| Pre-tax income | $4.9B | 28.59% | $18M | 5.41% | CSCO +23.2pp |
| Net income | $3.9B | 22.37% | $16M | 4.68% | CSCO +17.7pp |
| Stage | CSCO | EXTR | Gap · A − B |
|---|---|---|---|
| Revenue | $17.3B100.00% | $341M100.00% | CSCO ×50.58 |
| Gross profit | 64.13%$11.1B | 62.13%$212M | CSCO +2.0pp |
| Operating income | 24.72%$4.3B | 6.77%$23M | CSCO +17.9pp |
| Pre-tax income | 28.59%$4.9B | 5.41%$18M | CSCO +23.2pp |
| Net income |
| 22.37%$3.9B |
| 4.68%$16M |
| CSCO +17.7pp |
No disclosed counterparties: EXTR.
None